Introduction: Routine checkup is a form of preventive medicine, it’s a helpful practice to promote health in the community. Studying the prevalence of routine checkup, awareness, influencing, and preventing factors for it in our community will be a helpful tool for the health authorities to promote among individuals. Methodology: This cross-sectional study was conducted in different locations of Riyadh using a convenience sampling technique, with sample size of 414 Saudi participants of both genders aged 36 years old and above. The data were collected through self-administered structured questionnaire with demographic variables, frequency of routine medical checkup, knowledge questions, factors that enhance or prevent individual to do routine checkup and best way to spread the awareness. Results: Two hundred eighty-eight (69.57%) participants knew well about routine checkup and 142 (34.3%) of them do routine medical checkup. “Lack of time” and “Laziness” were reported as the 2 most common preventing factors (46% and 45.2%), respectively, and most common reason that influenced their practice was “health concern” (77.5%) followed by “worry about chronic or serious illness” (32.4%). Participants believed that social networks (eg, twitter, Facebook, etc) and media (eg, TV, radio) are most effective ways to spread awareness of it in the community (53.86% and 52.89%, respectively). Conclusion: There was high level of knowledge on routine health checkup, but a low prevalence was observed in practice. Hence, more health initiatives should be taken for routine medical screening in the Saudi community.
Background:Diabetes mellitus (DM) and vitamin D deficiency are major health concerns around the world. Evidence suggests a possible role of vitamin D in improvement of insulin secretion and sensitivity.Objectives:We assessed whether vitamin D supplementation could be used in vitamin D deficient-type II diabetes to improve glucose metabolism, components of metabolic syndrome (MetS) and specific inflammatory biomarkers.Patients and Methods:A double blind, randomized clinical trial was conducted in King Khalid University Hospital, Saudi Arabia to evaluate the effect of cholecalciferol supplementation on glycemic control, MetS components and specific inflammatory biomarkers including tumor necrosis factor-alpha (TNF-α), Interleukin (IL-6), leptin, adiponectin and vascular cell adhesion molecule-1 (VCAM-1). Twenty-two patients with type II diabetes with insulin resistance, glycated hemoglobin (HbA1c) ≥ 6 (42 mmol/mol) and serum 25(OH)D < 50 nmol/L were randomized using a computer program to receive either supplementation with cholecalciferol (5000 IU/day) or placebo for 12 weeks. The primary outcome was change in HbA1c levels from baseline.Results:Median [IQR] 25(OH)D levels increased significantly in the vitamin D group as 58.1 [48, 67.3] nmol/L (P = 0.002). There was no significant difference in the change of HbA1c between the groups (P = 0.5) with a decrease of -0.1% [-1, 0.5] in the vitamin D group and an increase of 0.15% [0.1, 0.2] in the placebo group. A significant improvement was observed in the homeostasis model of assessment of β-cell activity (HOMA-%B) (P = 0.03) with vitamin D supplementation compared to baseline.Conclusions:Vitamin D repletion for 12 weeks increased serum vitamin D concentrations and improved β-cell activity in vitamin D-deficient type II diabetes with no significant changes in HbA1c or insulin sensitivity.
Datascope Accutorr Plus™ (Paramus, NJ, USA) satisfies BHS and AAMI validation protocols for both systolic and diastolic BP and may be recommended for everyday use for BP monitoring at home and in clinical use for adult population.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.